Valenti L - Search Results

1

Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients.

Indirli R, Bandera A, Valenti L, Ceriotti F, Di Modugno A, Tettamanti M, Gualtierotti R, Peyvandi F, Montano N, Blasi F, Costantino G, Resi V, Orsi E, Arosio M, Mantovani G, Ferrante E; COVID-19 Network Working Group. Indirli R, et al. Among authors: valenti l. Eur J Clin Invest. 2022 May;52(5):e13753. doi: 10.1111/eci.13753. Epub 2022 Feb 7. Eur J Clin Invest. 2022. PMID: 35128648 Free PMC article.

2

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Gastroenterology. 2002 Feb;122(2):274-80. doi: 10.1053/gast.2002.31065. Gastroenterology. 2002. PMID: 11832442

3

TNFalpha promoter polymorphisms.

Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. Fargion S, et al. Among authors: valenti l. Methods Mol Med. 2004;98:47-58. doi: 10.1385/1-59259-771-8:047. Methods Mol Med. 2004. PMID: 15064432

4

Treatment choices for people infected with HCV.

Fargion S, Fracanzani AL, Valenti L. Fargion S, et al. Among authors: valenti l. J Antimicrob Chemother. 2004 May;53(5):708-12. doi: 10.1093/jac/dkh170. Epub 2004 Apr 8. J Antimicrob Chemother. 2004. PMID: 15073158 Review.

5

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, Gianni C, Fargion S. Valenti L, et al. J Hepatol. 2005 Dec;43(6):944-50. doi: 10.1016/j.jhep.2005.05.035. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143422

6

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S. Valenti L, et al. Am J Gastroenterol. 2007 Jun;102(6):1251-8. doi: 10.1111/j.1572-0241.2007.01192.x. Epub 2007 Mar 27. Am J Gastroenterol. 2007. PMID: 17391316

7

HFE genotype influences erythropoiesis support requirement in hemodialysis patients: a prospective study.

Valenti L, Valenti G, Como G, Santorelli G, Dongiovanni P, Rametta R, Fracanzani AL, Tavazzi D, Messa PG, Fargion S. Valenti L, et al. Among authors: valenti g. Am J Nephrol. 2008;28(2):311-6. doi: 10.1159/000111387. Epub 2007 Nov 16. Am J Nephrol. 2008. PMID: 18025780

8

Carotid artery intima-media thickness in nonalcoholic fatty liver disease.

Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S. Fracanzani AL, et al. Among authors: valenti l. Am J Med. 2008 Jan;121(1):72-8. doi: 10.1016/j.amjmed.2007.08.041. Am J Med. 2008. PMID: 18187076

9

Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation.

Valenti L, Guido M, Dongiovanni P, Cremonesi L, Fracanzani AL, Fargion S. Valenti L, et al. Dig Liver Dis. 2009 Jul;41(7):e17-20. doi: 10.1016/j.dld.2008.01.020. Epub 2008 Mar 11. Dig Liver Dis. 2009. PMID: 18337195

10

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L. Valenti L, et al. Osteoporos Int. 2009 Apr;20(4):549-55. doi: 10.1007/s00198-008-0701-4. Epub 2008 Jul 26. Osteoporos Int. 2009. PMID: 18661088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters